Divalproex Sodium

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

65 Suppliers, 35 USDMF, 10 CEP/COS, 3 JDMF, 7 EU WC, 9 KDMF, 15 NDC API, 33 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

234 Dossiers, 109 FDA Orange Book, 46 Europe, 17 Canada, 13 Australia, 17 South Africa, 32 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SYRUP;ORAL - 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 125MG VALPROIC ACID, TABLET, DELAYED RELEASE;ORAL - EQ 250MG VALPROIC ACID, TABLET, DELAYED RELEASE;ORAL - EQ 500MG VALPROIC ACID, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 125MG VALPROIC ACID, TABLET, EXTENDED RELEASE;ORAL - EQ 250MG VALPROIC ACID, TABLET, EXTENDED RELEASE;ORAL - EQ 500MG VALPROIC ACID

RELATED EXCIPIENT COMPANIES

Suppliers, 38 BASF, 34 Kerry, 27 Roquette, 19 SPI Pharma, 18 Microlex e.U, 18 Corel Pharma Chem, 16 Ideal Cures Pvt Ltd, 14 Seppic, 13 Gangwal Chemicals, 12 Sigachi Industries, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 Gangwal Healthcare, 9 Boai NKY Pharmaceuticals Ltd, 9 Nanjing Well Pharmaceutical, 8 Actylis, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Lonza Capsugel, 6 DFE Pharma, 5 Ingredion Pharma Solutions, 4 Vasa Pharmachem, 4 Kima Chemical, 4 ACG Worldwide, 4 Pharmatrans-Sanaq, 4 Prachin Chemical, 3 The Dow Chemical Company, 3 Doshion Polyscience, 3 Evonik, 3 Alcedo Pharmachem, 3 DKSH, 3 Rochem International Inc, 3 Ulanqab Kema New Material, 2 Nomisma Healthcare, 2 Jai Radhe Sales, 2 Clariant, 2 Qualicaps, 2 Pfanstiehl, 2 Seqens, 2 Finar, 2 Vertellus, 1 Avesta Pharma, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Aeon Procare, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Pharm-RX Chemical, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Nanjing Bold Chemical, 1 Huzhou Sunflower Pharmaceutical

EXCIPIENTS BY APPLICATIONS

97 Fillers, Diluents & Binders, 82 Coating Systems & Additives, 51 Controlled & Modified Release, 49 Direct Compression, 45 Disintegrants & Superdisintegrants, 38 Solubilizers, 34 Granulation, 32 Taste Masking, 30 Thickeners and Stabilizers, 27 Film Formers & Plasticizers, 21 Parenteral, 21 Lubricants & Glidants, 19 Topical, 18 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 10 API Stability Enhancers, 9 Emulsifying Agents, 9 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents

GLOBAL SALES INFORMATION

74 US Medicaid Prescriptions, 80 Finished Drug Prices

MARKET PLACE

24 APIs, 16 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 2 EDQM Standards, 3 USP Standards, 4 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 60 News

Manufacturers & Suppliers of Divalproex Sodium Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Divalproex Sodium

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

65 Suppliers

35 USDMF

10 CEP/COS

3 JDMF

7 EU WC

9 KDMF

15 NDC API

33 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

234 Dossiers

109 FDA Orange Book

46 Europe

17 Canada

13 Australia

17 South Africa

32 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SYRUP;ORAL - 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - EQ 125MG VALPROIC ACID

TABLET, DELAYED RELEASE;ORAL - EQ 250MG VALPROIC ACID

TABLET, DELAYED RELEASE;ORAL - EQ 500MG VALPROIC ACID

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 125MG VALPROIC ACID

TABLET, EXTENDED RELEASE;ORAL - EQ 250MG VALPROIC ACID

TABLET, EXTENDED RELEASE;ORAL - EQ 500MG VALPROIC ACID

RELATED EXCIPIENT COMPANIES

Suppliers

38 BASF

34 Kerry

27 Roquette

19 SPI Pharma

18 Microlex e.U

18 Corel Pharma Chem

16 Ideal Cures Pvt Ltd

14 Seppic

13 Gangwal Chemicals

12 Sigachi Industries

11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

11 Gangwal Healthcare

9 Boai NKY Pharmaceuticals Ltd

9 Nanjing Well Pharmaceutical

8 Actylis

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Lonza Capsugel

6 DFE Pharma

5 Ingredion Pharma Solutions

4 Vasa Pharmachem

4 Kima Chemical

4 ACG Worldwide

4 Pharmatrans-Sanaq

4 Prachin Chemical

3 The Dow Chemical Company

3 Doshion Polyscience

3 Evonik

3 Alcedo Pharmachem

3 DKSH

3 Rochem International Inc

3 Ulanqab Kema New Material

2 Nomisma Healthcare

2 Jai Radhe Sales

2 Clariant

2 Qualicaps

2 Pfanstiehl

2 Seqens

2 Finar

2 Vertellus

1 Avesta Pharma

1 Qianhao Chemical (Hebei) Co., Ltd

1 Aeon Procare

CAPSULE;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SYRUP;ORAL - 250MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons